ArticleJournal of experimental & clinical cancer research : CR2022

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers.

Li Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.